The pandemic influenza A(H1N1)pdm09 virus was first detected in India in May 2009 and continued to circulate in the postpandemic period. Whole-genome sequence analysis of postpandemic A(H1N1)pdm09 viruses showed the circulation of clade 6 and clade 7 viruses. The hemagglutinin (HA) gene showed increased diversity compared with that in the pandemic phase.
fter the first reported case of infection with the influenza A(H1N1)pdm09 virus in India (1), the virus was found to be in circulation in many parts of the country. A previous report (2) of 31 whole-genome sequences of the A(H1N1)pdm09 virus during a pandemic revealed higher substitution rates than those observed globally. In the postpandemic period, the A(H1N1)pdm09 virus remained in circulation and showed unusually increased activity and severity in March and April, especially in the northern and western parts of the country, for three consecutive years, which is unseasonal for India. The National Institute of Virology in Pune carried out diagnostic and genetic analyses as part of postpandemic surveillance (institutional review board [IRB] approved). Thirteen wholegenome sequences from isolates obtained from April 2011 to April 2013 were studied and compared with the 31 wholegenome sequences from the pandemic period (2) to identify the genomic changes responsible for pathogenesis and drug susceptibility of A(H1N1)pdm09.
During the study period, 6,836 samples were analyzed, and of the 1,675 real-time PCR positives, 1,036 (61.8%) were A(H1N1)pdm09, 242 (14%) were A(H3N2), and 397 (23%) were type B positive. Isolation was carried out with MDCK cells. Thirteen A(H1N1)pdm09 isolates from a period of unusual activity (2 isolates from 2011, 8 isolates from 2012, and 3 isolates from 2013) were selected for whole-genome sequencing. All the eight influenza gene segments were amplified in an overlapping manner by one-step conventional reverse transcriptase PCR (RT-PCR) using the whole-genome primers recommended by the WHO and the CDC (3). Sequencing was carried out by using the BigDye Terminator version 3.1 cycle sequencing ready reaction kit (ABI) and processing for capillary electrophoresis on an ABI 3730 DNA analyzer; sequences were curated using Sequencing Analysis version 5.3, and MEGA version 5.2 was used for sequence alignments.
All gene segments were compared with those of the vaccine component strain A/California/07/2009, along with those of the globally circulating strains. The result showed that A(H1N1)pdm09 viruses of clade 7 (D97N mutation) and clade 6 (A197T mutation) were in circulation. A single isolate from 2013 possessed D222N (D239N) in the receptor binding region of the hemagglutinin (HA) molecule (4). The HA gene mutations P83S, S84G, S183P, S185T, S203T, R223Q, E374K S451N, and I321V observed during the pandemic were also noted in the postpandemic period (1, 2). Newly identified mutations in HA were S143G, K283E, and E499K. Increased diversity in the HA gene was observed from 2011 to 2013. All isolates remained sensitive to neuraminidase inhibitor (NAI) drugs and showed N369K and V241I amino acid changes in the neuraminidase (NA) gene, which may facilitate the stability of resistant viruses (5) . Similarly, mutations noticed for the polymerase basic 2 (PB2) gene were D195N, V731I, and N456S; for PB1, the mutations were G154D, I397M, and I435T; for the polymerase acidic (PA) gene, they were V100I and I330V; for M1, K239R; for M2, D21G; for the nonstructural 1 (NS1) gene, L90I, N205S, and I111M/T; and for NS2, T48A and V49M.
Continued molecular surveillance and whole-genome sequencing are important for understanding significant evolutionary changes in this pandemic virus. Isolate  PB2  PB1  PA  HA  M  NP  NA  NS   NIV1112874 KF280652 KF280653 KF280654 KF280655 KF280656 KF280657 KF280658 KF280659  NIV1114854 KF280660 KF280661 KF280662 KF280663 KF280664 KF280665 KF280666 KF280667  NIV12388  KF280668 KF280669 KF280670 KF280671 KF280672 KF280673 KF280674 KF280675  NIV121716 KF280676 KF280677 KF280678 KF280679 KF280680 KF280681 KF280682 KF280683  NIV121717 KF280684 KF280685 KF280686 KF280687 KF280688 KF280689 KF280690 KF280691  NIV121773 KF280692 KF280693 KF280694 KF280695 KF280696 KF280697 KF280698 KF280699  NIV121778 KF280700 KF280701 KF280702 KF280703 KF280704 KF280705 KF280706 KF280707  NIV121939 KF280708 KF280709 KF280710 KF280711 KF280712 KF280713 KF280714 KF280715  NIV12946  KF280716 KF280717 KF280718 KF280719 KF280720 KF280721 KF280722 KF280723  NIV122268 KF280724 KF280725 KF280726 KF280727 KF280728 KF280729 KF280730 KF280731  NIV132467 KF280732 KF280733 KF280734 KF280735 KF280736 KF280737 KF280738 KF280739  NIV131845 KF280740 KF280741 KF280742 KF280743 KF280744 KF280745 KF280746 KF280747  NIV132194 KF280748 KF280749 KF280750 KF280751 KF280752 KF280753 KF280754 KF280755 a PB2, polymerase basic 2; PA, polymerase acidic; HA, hemagglutinin; M, matrix; NP, nucleoprotein; NA, neuraminidase; NS, nonstructural.
Nucleotide sequence accession numbers. The whole-genome sequences of 13 Indian A(H1N1) pdm09 isolates from the period 2011 to 2013 have been deposited in GenBank under accession no. KF280652 to KF280755; accession numbers are listed in Table 1 .
